Stress Granules & Neurodegenerative Disease: New Research
Groundbreaking research reveals the surprising role of stress granules in neurodegenerative diseases. This study, published in Molecular Cell, overturns previous assumptions, indicating that stress granules may actually protect against harmful amyloid fibril formation, a critical component in conditions like ALS and FTD. Scientists found that the interior of these cellular structures suppresses fibril formation, and mutations affecting their stability influence disease progression. News Directory 3 brings you the latest insights from St. Jude Children’s Research Hospital and Washington University in St. Louis,examining potential therapeutic interventions targeting stress granule dynamics. Discover what’s next in the fight against these debilitating conditions.
Stress Granules’ Role in Neurodegenerative Diseases Examined
A collaborative study by St. Jude Children’s Research Hospital and Washington University in St. Louis has shed light on the complex role of biomolecular condensation in neurodegenerative diseases. The research, published in molecular Cell, investigates how stress granules, which are biomolecular condensates formed during cellular stress, relate to the development of conditions like amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).
The study indicates that while amyloid fibrils, a hallmark of neurodegenerative diseases, can form on the surface of stress granules, the interior of these granules actually suppresses fibril formation. This suggests that stress granules may not be the primary drivers of these diseases, as previously thought.Researchers found that mutations that stabilize stress granules can reverse the effects of disease-causing mutations.
Tanja Mittag, PhD, of St. Jude Department of Structural Biology, emphasized the importance of understanding whether stress granules are protective or harmful. She said this knowledge is crucial for developing effective treatments for neurodegenerative diseases.
Rohit pappu, PhD, of Washington University in St. Louis,noted that the research demonstrates condensates detour proteins from pathological fibrillar solids.He added that the interactions driving condensation versus fibril formation are separable, which could lead to therapeutic interventions.
Researchers examined the protein hNRNPA1 and discovered that disease-linked mutations cause proteins to leave condensate interiors more quickly, facilitating fibril formation. Fatima Zaidi, PhD, of St. jude Department of Structural Biology, explained that condensates act as a sink for soluble proteins, but eventually, these proteins form stable fibrils.
Tapojyoti Das, PhD, also of St. Jude Department of Structural Biology, suggested that stress granules should be viewed as a potential protective barrier against disease, rather than a catalyst.
What’s next
These findings provide a foundation for exploring new therapeutic approaches that target stress granule dynamics to combat neurodegenerative diseases.